Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2021

Conditions
Endometrial Cancer
Interventions
DRUG

Palbociclib/placebo

Palbociclib or a placebo is administered together with standard of care letrozole

DRUG

Letrozole

Letrozole is standard of care in both arms

Trial Locations (1)

2100

NSGO-CTU, Copenhagen

All Listed Sponsors
collaborator

European Network of Gynaecological Oncological Trial Groups (ENGOT)

OTHER

collaborator

Gynecologic Cancer Intergroup (GCIG)

OTHER

collaborator

North Eastern German Society of Gynaecological Oncology

OTHER

collaborator

Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO)

UNKNOWN

collaborator

Grupo Español de Investigación en Cáncer de Ovario

OTHER

lead

Nordic Society of Gynaecological Oncology - Clinical Trials Unit

OTHER

NCT02730429 - Trial of Letrozole + Palbociclib/Placebo in Metastatic Endometrial Cancer | Biotech Hunter | Biotech Hunter